Oral contraceptives and cervical cancer

Comment

Loretta Brabin et al. Lancet. 2002.

. 2002 Aug 3;360(9330):409-10.

doi: 10.1016/S0140-6736(02)09577-6.

No abstract available

Comment on

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.
Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group. Moreno V, et al. Lancet. 2002 Mar 30;359(9312):1085-92. doi: 10.1016/S0140-6736(02)08150-3. Lancet. 2002. PMID: 11943255
Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.
Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group. Muñoz N, et al. Lancet. 2002 Mar 30;359(9312):1093-101. doi: 10.1016/S0140-6736(02)08151-5. Lancet. 2002. PMID: 11943256